These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 28417973)

  • 61. Absence of Wip1 partially rescues Atm deficiency phenotypes in mice.
    Darlington Y; Nguyen TA; Moon SH; Herron A; Rao P; Zhu C; Lu X; Donehower LA
    Oncogene; 2012 Mar; 31(9):1155-65. PubMed ID: 21765465
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Wip1 regulates wound healing by affecting activities of keratinocytes and endothelial cells through ATM-p53 and mTOR signaling.
    Yu N; Li T; Qiu Z; Xu J; Li Y; Huang J; Yang Y; Li Z; Long X; Zhang H
    Burns; 2023 Dec; 49(8):1969-1982. PubMed ID: 37357059
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Signaling networks, network pathology and computational chemotherapy.
    Cho KH
    Oncotarget; 2013 Feb; 4(2):178-9. PubMed ID: 23563503
    [No Abstract]   [Full Text] [Related]  

  • 64. The p53 protein and its molecular network: modelling a missing link between DNA damage and cell fate.
    Eliaš J; Dimitrio L; Clairambault J; Natalini R
    Biochim Biophys Acta; 2014 Jan; 1844(1 Pt B):232-47. PubMed ID: 24113167
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Conservation and Divergence of p53 Oscillation Dynamics across Species.
    Stewart-Ornstein J; Cheng HWJ; Lahav G
    Cell Syst; 2017 Oct; 5(4):410-417.e4. PubMed ID: 29055670
    [TBL] [Abstract][Full Text] [Related]  

  • 66. PDCD5 functions as a regulator of p53 dynamics in the DNA damage response.
    Zhuge C; Sun X; Chen Y; Lei J
    J Theor Biol; 2016 Jan; 388():1-10. PubMed ID: 26433055
    [TBL] [Abstract][Full Text] [Related]  

  • 67. WIP1 modulates responsiveness to Sonic Hedgehog signaling in neuronal precursor cells and medulloblastoma.
    Wen J; Lee J; Malhotra A; Nahta R; Arnold AR; Buss MC; Brown BD; Maier C; Kenney AM; Remke M; Ramaswamy V; Taylor MD; Castellino RC
    Oncogene; 2016 Oct; 35(42):5552-5564. PubMed ID: 27086929
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dynamic behavior of P53-Mdm2-Wip1 gene regulatory network under the influence of time delay and noise.
    Luo L; Liu H; Yan F
    Math Biosci Eng; 2023 Jan; 20(2):2321-2347. PubMed ID: 36899536
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway.
    Zhang X; Wan G; Mlotshwa S; Vance V; Berger FG; Chen H; Lu X
    Cancer Res; 2010 Sep; 70(18):7176-86. PubMed ID: 20668064
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Fortifying p53 - beyond Mdm2 inhibitors.
    Sriraman A; Li Y; Dobbelstein M
    Aging (Albany NY); 2016 Sep; 8(9):1836-1837. PubMed ID: 27688014
    [No Abstract]   [Full Text] [Related]  

  • 71. Chemical Features Important for Activity in a Class of Inhibitors Targeting the Wip1 Flap Subdomain.
    Tagad HD; Debnath S; Clausse V; Saha M; Mazur SJ; Appella E; Appella DH
    ChemMedChem; 2018 May; 13(9):894-901. PubMed ID: 29476592
    [TBL] [Abstract][Full Text] [Related]  

  • 72. p53-Independent expression of wild-type p53-induced phosphatase 1 (Wip1) in methylmethane sulfonate-treated cancer cell lines and human tumors.
    Park JY; Song JY; Kim HM; Han HS; Seol HS; Jang SJ; Choi J
    Int J Biochem Cell Biol; 2012 Jun; 44(6):896-904. PubMed ID: 22405851
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Single-cell analysis of p53 transitional dynamics unravels stimulus- and cell type-dependent signaling output motifs.
    Xie J; Zhang L; Liu B; Liang X; Shi J
    BMC Biol; 2022 Apr; 20(1):85. PubMed ID: 35410287
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Inhibition of WIP1 in A549 cells enhances the sensitivity of cells to arsenic treatment].
    Luo Q; Gu S; Zhang Z
    Wei Sheng Yan Jiu; 2017 May; 46(3):389-395. PubMed ID: 29903248
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Activation and control of p53 tetramerization in individual living cells.
    Gaglia G; Guan Y; Shah JV; Lahav G
    Proc Natl Acad Sci U S A; 2013 Sep; 110(38):15497-501. PubMed ID: 24006363
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The biological function and the regulatory roles of wild-type p53-induced phosphatase 1 in immune system.
    Shi L; Tian Q; Feng C; Zhang P; Zhao Y
    Int Rev Immunol; 2020; 39(6):280-291. PubMed ID: 32696682
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mathematical Modeling of p53 Pathways.
    Kim E; Kim JY; Lee JY
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635420
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Wip1 phosphatase modulates ATM-dependent signaling pathways.
    Shreeram S; Demidov ON; Hee WK; Yamaguchi H; Onishi N; Kek C; Timofeev ON; Dudgeon C; Fornace AJ; Anderson CW; Minami Y; Appella E; Bulavin DV
    Mol Cell; 2006 Sep; 23(5):757-64. PubMed ID: 16949371
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Inhibition of the DNA damage response phosphatase PPM1D reprograms neutrophils to enhance anti-tumor immune responses.
    Uyanik B; Goloudina AR; Akbarali A; Grigorash BB; Petukhov AV; Singhal S; Eruslanov E; Chaloyard J; Lagorgette L; Hadi T; Baidyuk EV; Sakai H; Tessarollo L; Ryffel B; Mazur SJ; Lirussi F; Garrido C; Appella E; Demidov ON
    Nat Commun; 2021 Jun; 12(1):3622. PubMed ID: 34131120
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Feedbacks, Bifurcations, and Cell Fate Decision-Making in the p53 System.
    Hat B; Kochańczyk M; Bogdał MN; Lipniacki T
    PLoS Comput Biol; 2016 Feb; 12(2):e1004787. PubMed ID: 26928575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.